Key Details
Annual Revenue
$299.52 MAnnual EPS
-$6.07Annual ROE
258.65%Beta
-Events Calendar
Next earnings date:
N/ARecent quarterly earnings:
Nov 10, 2023Recent annual earnings:
Mar 06, 2023Next ex-dividend date:
N/ARecent ex-dividend date:
N/ANext split:
N/ARecent split:
N/AAnalyst ratings
Recent major analysts updates
Screeners with TRHC included
Market Data
Dividend
Profitability
Efficiency
Valuation
Liquidity
Cash Flow
Institutional Ownership
Similar stocks
AnewHealth provides transformative pharmacy solutions that elevate care and help providers and payers overcome the unique challenges of caring for the most at-risk patients in healthcare AnewHealth provides transformative pharmacy solutions that elevate care and help providers and payers overcome the unique challenges of caring for the most at-risk patients in healthcare
The company also announced improved revenue in its second-quarter earnings. The deal is expected to be completed by the fourth quarter of 2023.
Although the revenue and EPS for Tabula Rasa Healthcare (TRHC) give a sense of how its business performed in the quarter ended June 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Tabula Rasa Healthcare (TRHC) came out with quarterly earnings of $0.05 per share, beating the Zacks Consensus Estimate of a loss of $0.14 per share. This compares to loss of $0.32 per share a year ago.
Tabula Rasa HealthCare Inc shares were 30% higher in premarket trading after news that the healthcare company is to be acquired by private-equity firm Nautic Partners. The all-cash deal is for approximately $570 million, including debt of around $262 million.
Tabula Rasa Healthcare (TRHC) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
Tabula Rasa Healthcare (TRHC) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
Tabula Rasa Healthcare (TRHC) came out with a quarterly loss of $0.02 per share versus the Zacks Consensus Estimate of a loss of $0.15. This compares to loss of $0.33 per share a year ago.
FAQ
- What is the primary business of Tabula Rasa HealthCare?
- What is the ticker symbol for Tabula Rasa HealthCare?
- Does Tabula Rasa HealthCare pay dividends?
- What sector is Tabula Rasa HealthCare in?
- What industry is Tabula Rasa HealthCare in?
- What country is Tabula Rasa HealthCare based in?
- When did Tabula Rasa HealthCare go public?
- Is Tabula Rasa HealthCare in the S&P 500?
- Is Tabula Rasa HealthCare in the NASDAQ 100?
- Is Tabula Rasa HealthCare in the Dow Jones?
- When was Tabula Rasa HealthCare's last earnings report?
- When does Tabula Rasa HealthCare report earnings?
- Should I buy Tabula Rasa HealthCare stock now?